Logo image of AAGR

AFRICAN AGRICULTURE HOLDINGS (AAGR) Stock Fundamental Analysis

NASDAQ:AAGR - Nasdaq - US00792J1007 - Common Stock - Currency: USD

0.1326  -0.01 (-9.05%)

After market: 0.0627 -0.07 (-52.71%)

Fundamental Rating

0

AAGR gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. AAGR may be in some trouble as it scores bad on both profitability and health. AAGR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AAGR had negative earnings in the past year.
AAGR had a negative operating cash flow in the past year.
AAGR Yearly Net Income VS EBIT VS OCF VS FCFAAGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

AAGR has a Return On Assets of -20.08%. This is in the lower half of the industry: AAGR underperforms 76.09% of its industry peers.
AAGR has a worse Return On Equity (-294.89%) than 88.04% of its industry peers.
Industry RankSector Rank
ROA -20.08%
ROE -294.89%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AAGR Yearly ROA, ROE, ROICAAGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AAGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AAGR Yearly Profit, Operating, Gross MarginsAAGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

0

2. Health

2.1 Basic Checks

AAGR has less shares outstanding than it did 1 year ago.
The debt/assets ratio for AAGR is higher compared to a year ago.
AAGR Yearly Shares OutstandingAAGR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M 25M
AAGR Yearly Total Debt VS Total AssetsAAGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

AAGR has an Altman-Z score of -2.70. This is a bad value and indicates that AAGR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.70, AAGR is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.06 is on the high side and indicates that AAGR has dependencies on debt financing.
AAGR's Debt to Equity ratio of 1.06 is on the low side compared to the rest of the industry. AAGR is outperformed by 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z -2.7
ROIC/WACCN/A
WACCN/A
AAGR Yearly LT Debt VS Equity VS FCFAAGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.01 indicates that AAGR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.01, AAGR is doing worse than 97.83% of the companies in the same industry.
A Quick Ratio of 0.01 indicates that AAGR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.01, AAGR is doing worse than 97.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
AAGR Yearly Current Assets VS Current LiabilitesAAGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

AAGR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.21%.
EPS 1Y (TTM)-12.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AAGR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAGR Price Earnings VS Forward Price EarningsAAGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAGR Per share dataAAGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AAGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AFRICAN AGRICULTURE HOLDINGS

NASDAQ:AAGR (9/25/2024, 8:00:00 PM)

After market: 0.0627 -0.07 (-52.71%)

0.1326

-0.01 (-9.05%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.47%
Inst Owner Change3.84%
Ins Owners56.21%
Ins Owner Change0%
Market Cap7.67M
AnalystsN/A
Price TargetN/A
Short Float %0.4%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5
P/tB 5
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.08%
ROE -294.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -2.7
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-204.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-204.76%
OCF growth 3YN/A
OCF growth 5YN/A